Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.
about
Clinical Pharmacology and Translational Aspects of Bispecific AntibodiesOutpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.Expression and clinical significance of colorectal cancer stem cell marker EpCAM(high)/CD44(+) in colorectal cancer.Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linkerA phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3.
P2860
Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Systemic effect of catumaxomab ...... orectal cancer: a case report.
@ast
Systemic effect of catumaxomab ...... orectal cancer: a case report.
@en
type
label
Systemic effect of catumaxomab ...... orectal cancer: a case report.
@ast
Systemic effect of catumaxomab ...... orectal cancer: a case report.
@en
prefLabel
Systemic effect of catumaxomab ...... orectal cancer: a case report.
@ast
Systemic effect of catumaxomab ...... orectal cancer: a case report.
@en
P2093
P2860
P356
P1433
P1476
Systemic effect of catumaxomab ...... orectal cancer: a case report.
@en
P2093
Angelika Bezan
Florian Hohla
Richard Greil
Thomas Meissnitzer
P2860
P2888
P356
10.1186/1471-2407-13-618
P407
P577
2013-12-31T00:00:00Z
P5875
P6179
1009441062